高级检索
刘坤, 董缙, 孙菁, 储昭兴, 何书英, 徐云根. 来那度胺及其氨基糖偶联物的合成及抗肿瘤血管生成活性[J]. 中国药科大学学报, 2012, 43(6): 486-491.
引用本文: 刘坤, 董缙, 孙菁, 储昭兴, 何书英, 徐云根. 来那度胺及其氨基糖偶联物的合成及抗肿瘤血管生成活性[J]. 中国药科大学学报, 2012, 43(6): 486-491.
LIU Kun, DONG Jin, SUN Jing, CHU Zhao-xing, HE Shu-ying, XU Yun-gen. Synthesis and anti-angiogenesis evaluation of mutual prodrugs of lenalidomide and glucosamines[J]. Journal of China Pharmaceutical University, 2012, 43(6): 486-491.
Citation: LIU Kun, DONG Jin, SUN Jing, CHU Zhao-xing, HE Shu-ying, XU Yun-gen. Synthesis and anti-angiogenesis evaluation of mutual prodrugs of lenalidomide and glucosamines[J]. Journal of China Pharmaceutical University, 2012, 43(6): 486-491.

来那度胺及其氨基糖偶联物的合成及抗肿瘤血管生成活性

Synthesis and anti-angiogenesis evaluation of mutual prodrugs of lenalidomide and glucosamines

  • 摘要: 为提高来那度胺对肿瘤组织的靶向性,利用前药原理,通过丁二酰基或戊二酰基将来那度胺与氨基糖进行偶联,设计合成了8个来那度胺和氨基糖偶联物( 4a~4h ),其结构均经IR、1H NMR、MS、元素分析确证。初步体外实验结果显示化合物 4a~4c 能够抑制血管内皮细胞的增殖。

     

    Abstract: To improve the targeting effect of lenalidomide on cancer cells,eight coupling compounds( 4a-4h ) of lenalidomide and aminosaccharides were designed and synthesizedTheir structures were characterized by IR,1H NMR,MS and elemental analysisPreliminary biological evaluation results showed that compounds 4a-4c could inhibit HUVEC cell proliferation in vitro.

     

/

返回文章
返回